Treatment resistant schizophrenia and neurological soft signs may converge on the same pathology: Evidence from explanatory analysis on clinical, psychopathological, and cognitive variables

被引:28
作者
de Bartolomeis, Andrea [1 ]
Prinzivalli, Emiliano [1 ]
Callovini, Gemma [1 ]
D'Ambrosio, Luigi [1 ]
Altavilla, Benedetta [1 ]
Avagliano, Camilla [1 ]
Iasevoli, Felice [1 ]
机构
[1] Univ Sch Med Federico II, Dept Neurosci, Lab Mol & Translat Psychiat, Sect Psychiat,Unit Treatment Resistant Psychosis, Naples, Italy
关键词
1ST-EPISODE SCHIZOPHRENIA; NEUROPSYCHOLOGICAL PERFORMANCE; ANTIPSYCHOTIC TREATMENT; TREATMENT RESPONSE; NEGATIVE SYMPTOMS; SCALE; ABNORMALITIES; INSTRUMENT; PREDICTORS; REMISSION;
D O I
10.1016/j.pnpbp.2017.09.002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Here, we investigated neurological soft signs (NSSs) in treatment resistant schizophrenia (TRS) vs treatment responder schizophrenia (SZ) patients. TRS is a severe condition, affecting approximately one-third of schizophrenia patients and representing a relevant clinical challenge. NSSs are neurological abnormalities reportedly described in schizophrenia patients and linked to dysregulated network connections. We explored the possibility that NSSs may be: i) more severe in TRS patients; ii) differentially associated to clinical/cognitive variables in TRS vs SZ; iii) predictive of having TRS. In addition, we evaluated whether diagnosis may mediate NSSs associations with the above-mentioned variables. Consecutive patients with schizophrenia diagnosis underwent stringent assessment for TRS diagnosis. Demographics and clinical variables were recorded. Psychopathology (by Positive and Negative Syndrome Scale, PANSS), cognitive performances, and NSSs (by Neurological Evaluation Scale, NES) were tested. TRS had higher scores than SZ patients in total NES score and in almost all NES subscales, even after correction for duration of illness and antipsychotic dose (ANCOVA, p < 0.05). NSSs significantly correlated with multiple clinical, psychopathological, and cognitive variables (above all: duration of disease and negative symptoms) in TRS but not in SZ patients. Two-way ANOVA showed NSS-x-diagnosis interaction in determining outcomes on multiple cognitive performances, but not in other clinical variables. However, simple main effect analysis detected a significant relationship between high severity NSSs and TRS diagnosis on multiple clinical and cognitive outcomes. Hierarchical regression analysis showed that diagnosis was among a discrete number of predictors yielding significant increases in variance explained on NES total, Sensory Integration and Other Signs subscales' scores. NSSs, together with antipsychotic dose and disease severity, were found to be significantly predictive of TRS diagnosis in a binary logistic regression model. These results suggest a stringent association between NSSs and TRS diagnosis, and may imply that NSSs association with clinical, psychopathological, and cognitive variables may be in part mediated by TRS diagnosis.
引用
收藏
页码:356 / 366
页数:11
相关论文
共 77 条
  • [51] Linking the PANSS, BPRS, and CGI: Clinical implications
    Leucht, Stefan
    Kane, John M.
    Etschel, Eva
    Kissling, Werner
    Hamann, Johannes
    Engel, Rolf R.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 (10) : 2318 - 2325
  • [52] Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future
    Li, Peng
    Snyder, Gretchen L.
    Vanover, Kimberly E.
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (29) : 3385 - 3403
  • [53] Neurological soft signs and schizotypal dimensions in unaffected siblings of patients with schizophrenia
    Mechri, Anwar
    Gassab, Leila
    Slama, Hela
    Gaha, Lotfi
    Saoud, Mohamed
    Krebs, Marie Odile
    [J]. PSYCHIATRY RESEARCH, 2010, 175 (1-2) : 22 - 26
  • [54] Neurological soft signs in patients with schizophrenia and their unaffected siblings: frequency and correlates in two ethnic and socioeconomic distinct populations
    Mechri, Anwar
    Bourdel, Marie-Chantal
    Slama, Hela
    Gourion, David
    Gaha, Lotfi
    Krebs, Marie-Odile
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2009, 259 (04) : 218 - 226
  • [55] MELTZER HY, 1990, SCHIZOPHRENIA BULL, V16, P563, DOI 10.1093/schbul/16.4.563
  • [56] Relation of neurological soft signs to psychiatric symptoms in schizophrenia
    Mittal, Vijay A.
    Hasenkamp, Wendy
    Sanfilipo, Michael
    Wieland, Susan
    Angrist, Burton
    Rotrosen, John
    Duncan, Erica J.
    [J]. SCHIZOPHRENIA RESEARCH, 2007, 94 (1-3) : 37 - 44
  • [57] Neurological soft signs and neuropsychological performance in patients with first episode schizophrenia
    Mohr, F
    Hubmann, W
    Albus, M
    Franz, U
    Hecht, S
    Scherer, J
    Binder, J
    Sobizack, N
    [J]. PSYCHIATRY RESEARCH, 2003, 121 (01) : 21 - 30
  • [58] Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive
    Mouchlianitis, Elias
    Bloomfield, Michael A. P.
    Law, Vincent
    Beck, Katherine
    Selvaraj, Sudhakar
    Rasquinha, Naresh
    Waldman, Adam
    Turkheimer, Federico E.
    Egerton, Alice
    Stone, James
    Howes, Oliver D.
    [J]. SCHIZOPHRENIA BULLETIN, 2016, 42 (03) : 744 - 752
  • [59] Is the PANSS used correctly? a systematic review
    Obermeier, Michael
    Schennach-Wolff, Rebecca
    Meyer, Sebastian
    Moeller, Hans-Juergen
    Riedel, Michael
    Krause, Daniela
    Seemueller, Florian
    [J]. BMC PSYCHIATRY, 2011, 11
  • [60] Characterization of the Deficit Syndrome in Drug-Naive Schizophrenia Patients: The Role of Spontaneous Movement Disorders and Neurological Soft Signs
    Peralta, Victor
    Moreno-Izco, Lucia
    Sanchez-Torres, Ana
    Garcia de Jalon, Elena
    Campos, Maria S.
    Cuesta, Manuel J.
    [J]. SCHIZOPHRENIA BULLETIN, 2014, 40 (01) : 214 - 224